These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33539671)

  • 1. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
    Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
    Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.
    Scott SN; Ostrovnaya I; Lin CM; Bouvier N; Bochner BH; Iyer G; Solit D; Berger MF; Lin O
    Cancer Cytopathol; 2017 Jun; 125(6):416-426. PubMed ID: 28339163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer.
    Dugas SG; Müller DC; Le Magnen C; Federer-Gsponer J; Seifert HH; Ruiz C; Savic Prince S; Vlajnic T; Zellweger T; Mertz KD; Bacon JVW; Wyatt AW; Rentsch CA; Bubendorf L
    Cancer Cytopathol; 2019 Sep; 127(9):578-585. PubMed ID: 31386310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
    Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
    Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual immunocytochemical staining of annexin A10 and p53 in low-grade and papillary urothelial carcinoma contributes to improvement of diagnostic accuracy in urine cytology.
    Kobayashi G; Hayashi T; Sentani K; Uraoka N; Shibata J; Nobuhiro R; Saito Y; Ishida K; Kaneko Y; Ikeda K; Hanamoto M; Nose H; Arihiro K; Hinata N; Oue N
    Cancer Cytopathol; 2023 Sep; 131(9):548-560. PubMed ID: 37300383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine Cytology Findings in Cases of Pseudocarcinomatous Urothelial Hyperplasia of the Bladder Often Represent a Diagnostic Challenge.
    Velez Torres JM; Gonzalez ML; Duarte EM; Zein-Sabatto B; Aron M; Gupta NS; Kerr DA; Netto GJ; Jorda M; Kryvenko ON
    Arch Pathol Lab Med; 2023 Jun; 147(6):716-721. PubMed ID: 36191340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of positive and suspicious urine cytology: Are they different?
    Kuan KC; Segura SE; Ahlstedt J; Khader SN; Hakima L
    Diagn Cytopathol; 2020 Nov; 48(11):998-1002. PubMed ID: 32558388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital].
    Zhao H; Zhang ZH; Guo HQ; Wei N; Ma HY; Zhao LL; Sun Y; Wang C; Chang XX; Bi XG; Xing NZ
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):703-709. PubMed ID: 39034806
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
    Celik B; Kavas G
    Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High apoptotic index in urine cytology is associated with high-grade urothelial carcinoma.
    Yang CS; Chen S; Cramer HM; Wu HH
    Cancer Cytopathol; 2016 Aug; 124(8):546-51. PubMed ID: 27070653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning.
    Tsuji K; Kaneko M; Harada Y; Fujihara A; Ueno K; Nakanishi M; Konishi E; Takamatsu T; Horiguchi G; Teramukai S; Ito-Ihara T; Ukimura O
    Eur Urol Oncol; 2024 Apr; 7(2):258-265. PubMed ID: 38065702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
    Yamasaki M; Taoka R; Katakura K; Matsunaga T; Kani N; Honda T; Harada S; Tohi Y; Matsuoka Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Haba R; Sugimoto M
    BMC Urol; 2022 Apr; 22(1):51. PubMed ID: 35382830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
    Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
    Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
    Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H
    J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.
    Eich ML; Rodriguez Pena MDC; Springer SU; Taheri D; Tregnago AC; Salles DC; Bezerra SM; Cunha IW; Fujita K; Ertoy D; Bivalacqua TJ; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Netto GJ
    Mod Pathol; 2019 Oct; 32(10):1544-1550. PubMed ID: 31028363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
    Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
    Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional cell groups with disordered nuclei and cellular discohesion (3DDD) are associated with high sensitivity and specificity for cystoscopic urine cytopathological diagnosis of low-grade urothelial neoplasia.
    Mai KT; Ball CG; Kos Z; Belanger EC; Islam S; Sekhon H
    Diagn Cytopathol; 2014 Jul; 42(7):555-63. PubMed ID: 24273035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of urine cytology in detecting histologic variants of urothelial carcinomas in the urinary bladder: Cytopathologic correlation of 72 cases.
    Yoo Y; Choi E; Lee DH; Park S; Sung SH
    Diagn Cytopathol; 2021 Mar; 49(3):367-373. PubMed ID: 33331144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of urine cytology in detecting high-grade urothelial carcinoma in patients with neoplastic urinary bladder diverticula: A major cancer center experience.
    Alhamar M; Al-Ahmadie HA; Feratovic R; Lin O
    Cancer Cytopathol; 2024 Mar; 132(3):144-151. PubMed ID: 38054371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.